首页|期刊导航|北京中医药大学学报|从顽痰伏络论治耐药铜绿假单胞菌所致肺部感染

从顽痰伏络论治耐药铜绿假单胞菌所致肺部感染OA

Treating drug-resistant Pseudomonas aeruginosa-induced pulmonary infection from the perspective of stubborn phlegm lurking in the collaterals

中文摘要英文摘要

耐药铜绿假单胞菌所致肺部感染常见于高龄、慢性气道疾病、反复住院或既往多次接受抗菌药物治疗者,具有病原清除困难、病程迁延、急性加重反复发作及感染控制后仍遗留呼吸道症状等特点.本文基于中医学对痰、伏邪与络病的相关认识,提出从顽痰伏络论治耐药铜绿假单胞菌所致肺部感染,认为正虚为发病基础,热毒犯肺、灼津成痰,痰浊久留,渐成顽痰,顽痰与热毒、瘀血相互搏结,深伏肺络,致邪伏不去、遇机复动,呈现正虚与邪实并见、热毒与痰浊相结、顽痰留伏与痰瘀互结相继加深的病机特点.治疗当以扶正祛邪、化痰通络、分期论治为总则.急性发作期及迁延反复期均以加味扶正解毒化瘀方为基础,前者重清热解毒、化痰排脓,佐以扶正,后者重清热化痰、软坚通络、兼清余毒;恢复期以桔杏君子颗粒益气养阴、调补脾肺、兼化残痰.上述辨治思路可为耐药铜绿假单胞菌所致肺部感染的中医药辨治提供参考.

Pulmonary infection caused by drug-resistant Pseudomonas aeruginosa frequently occurs in older patients and in those with chronic airway diseases,recurrent hospitalizations,or repeated prior exposure to antimicrobial agents.It is characterized by difficulty in eradicating the pathogen,a protracted clinical course,recurrent acute exacerbations,and persistent respiratory symptoms even after infection control.Based on the traditional Chinese medicine(TCM)theories concerning phlegm,latent pathogens,and collateral diseases,this paper proposes a therapeutic approach for pulmonary infection induced by drug-resistant Pseudomonas aeruginosa from the perspective of stubborn phlegm lurking in lung collaterals.Deficiency of the body's vital resistance is considered as the pathogenic basis,whereas lung invasion by heat toxin and body fluid consumption with subsequent phlegm formation constitute the initial pathogenic process.As phlegm turbidity persists,it gradually develops into stubborn phlegm,which interacts with heat toxin and blood stasis and becomes deeply lodged in the pulmonary collaterals.This result in the persistence of pathogenic factors and their reactivation under triggering conditions.Thus,the pathogenesis is characterized by the coexistence of vital resistance deficiency and pathogenic excess,the intermingling of heat toxin and phlegm turbidity,and the progressive aggravation of stubborn phlegm retention,latent pathogenic factors in the collaterals,and phlegm-blood stasis binding.Treatment should strengthen the body's vital resistance,eliminate pathogenic factors,resolve phlegm,unblock the collaterals,and follow stage-based management.The acute exacerbation and protracted and recurrent stages are treated with modified Fuzheng Jiedu Huayu Formula as the basic prescription.During acute exacerbations,emphasis is placed on clearing heat and detoxifying,resolving phlegm and discharging pus,with concurrent support for the body's vital resistance.During the protracted or recurrent stage,treatment focuses on clearing heat,resolving phlegm,softening hardness,unblocking the collaterals,and eliminating residual toxins.During recovery,Jiexing Junzi Granules are used to replenish qi and nourish yin,regulate and tonify the spleen and lung,and resolve residual phlegm.This therapeutic framework provides a reference for the TCM management of pulmonary infection caused by drug-resistant Pseudomonas aeruginosa.

王禹霖;于会勇;王毅;满天;胡明凯;崔泰宁;王成祥

北京中医药大学第三附属医院 北京 100029北京中医药大学第三附属医院 北京 100029北京中医药大学第三附属医院 北京 100029北京中医药大学第三附属医院 北京 100029北京中医药大学第三附属医院 北京 100029北京中医药大学第三附属医院 北京 100029北京中医药大学第三附属医院 北京 100029

医药卫生

耐药铜绿假单胞菌肺部感染顽痰伏络分期论治化痰通络

drug-resistant Pseudomonas aeruginosapulmonary infectionstubborn phlegm lurking in the collateralsstage-based treatmentresolving phlegm and unblocking the collaterals

《北京中医药大学学报》 2026 (9)

1292-1298,7

首都卫生发展科研专项(No.2022-2-7034)中华中医药学会联合攻关项目2025 年度优势病种专项(No.NCIM25-2) Capital Health Development Research Project(No.2022-2-7034)

10.3969/j.issn.1006-2157.2026.09.013

评论